跳至主要内容
临床试验/DRKS00030073
DRKS00030073招募中不适用

Hi-SMILE: Prospective study on stereotactic minimally-invasive laser interstitial thermal therapy in patients with recurrent glioblastoma and high-grade glioma - Hi-SMILE

eurochirurgische KlinikSektion stereotaktische NeurochirurgieUniversitätsklinikum Heidelberg0 个研究点目标入组 30 人开始时间: 2022年8月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients of legal age with previously histologically confirmed glioblastoma or high-grade glioma (CNS WHO 4°) and
  • imaging suspicion of supratentorial recurrence
  • - Indication for LITT treatment with biopsy sampling if open resection is considered too risky
  • resection is deemed too risky or not possible by specialist neurosurgeon.
  • (Common factors in favor of LITT treatment:
  • a) tumor volume <30cm3 and/or <3cm diameter along the
  • longest axis of extension
  • b) Karnofsky Performance Index of 70% or higher).

排除标准

  • - Patients not able to give consent
  • - MRI imaging not possible
  • - Expected survival <3 months
  • - Presence of absolute contraindications for general anesthesia and/or surgery
  • - Pregnant patients

研究者

发起方
eurochirurgische KlinikSektion stereotaktische NeurochirurgieUniversitätsklinikum Heidelberg

相似试验